Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...

Phase 2 on the roadmap focuses on core protocol readiness. This includes finalizing smart contracts, preparing liquidity ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...

In crypto, the largest shifts are hardly visible at some point when all is clear. They are likely to transpire when a project ...

Mutuum Finance (MUTM) continues to gather momentum as its funding milestone crosses $19.4M and Phase 6 of its token ...

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, NE / ACCESS Newswire / December 23, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A ...

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease ...

Microsoft CEO Satya Nadella said the world is entering a new era where the "frontier of what is possible" is rapidly ...

NASA advances heliophysics mission concepts as CINEMA enters Phase B for flight planning and CMEx receives an extended Phase A study for further design assessment.

Most people are familiar with AI tools that generate text or images. Famous AI extends beyond these basic capabilities. Users ...

The dynamic, automated, continuous risk management framework addresses the shortcomings of its predecessor, the Risk ...

The token presale began in early 2025. At launch, MUTM was priced at $0.01. Since then, the token has climbed steadily ...